Hexarelin (Examorelin)
Fat LossGHRP / researchExperimental
Potent GHRP (examorelin) that raises GH and can desensitize with frequent use. Also studied for cardiac GHSR effects. Not FDA-approved. WADA S2.
For research use only.
Key Facts
- CAS
- 140703-51-1
- Molecular Weight (MW)
- 887.0 g/mol
- Half-life
- ~56–76 minutes (human PK studies)
- Unit
- mcg
- Administration Route
- SC/IV in studies
- Frequency
- —
- Last updated
- 8/23/2026
- Targets
- GHSR
Overview
Potent GHRP (examorelin) that raises GH and can desensitize with frequent use. Also studied for cardiac GHSR effects. Not FDA-approved. WADA S2.
Protocol
- Dosage Range
- Per research protocol
- Frequency
- —
- Cycle
- —
- Administration Route
- SC/IV in studies
- Reconstitution Guide
- —
Science
Mechanism of Action
GHSR agonist producing robust GH release; repeated dosing can attenuate the GH response. Cardiac GHSR binding has been explored independently of GH.
Targets
GHSR
Studies
- Hexarelin GH secretion— Journal/year not available
Benefits
Potent GH-axis probeCardiac GHSR research
Potential Side Effects
- Cortisol/prolactin rise
- Hunger
- Desensitization
References
- PMID 8748432External link · Year —
- WADA Prohibited List 2026External link · Year —